| HAL CNRS portal |  |
Journal articles
Redifferentiation-facilitated radioiodine therapy in thyroid cancer
Abstract : Based on experimental data, the inhibition of the MAPkinase pathway in patients with radioiodine-refractory thyroid cancer was capable of inducing a redifferentiation. Preliminary data obtained in a small series of patients were encouraging and this strategy might become an alternative treatment in those patients with a druggable mutation that induces a stimulation of the MAP kinase pathway. This is an active field of research to answer many still unresolved questions.
https://hal-cnrs.archives-ouvertes.fr/hal-03445754
Contributor : Corinne DUPUY Connect in order to contact the contributor
Submitted on : Thursday, November 25, 2021 - 8:18:33 AM
Last modification on : Saturday, June 25, 2022 - 3:45:27 AM
Long-term archiving on: : Saturday, February 26, 2022 - 6:04:25 PM
Contributor : Corinne DUPUY Connect in order to contact the contributor
Submitted on : Thursday, November 25, 2021 - 8:18:33 AM
Last modification on : Saturday, June 25, 2022 - 3:45:27 AM
Long-term archiving on: : Saturday, February 26, 2022 - 6:04:25 PM
File
ERCREIFFERENTIATION_24122020_N...
Files produced by the author(s)